Stay updated on iTRAP: ADI-PEG 20 Combo in Arginine-Req Tumours Clinical Trial
Sign up to get notified when there's something new on the iTRAP: ADI-PEG 20 Combo in Arginine-Req Tumours Clinical Trial page.

Latest updates to the iTRAP: ADI-PEG 20 Combo in Arginine-Req Tumours Clinical Trial page
- Check4 days agoChange DetectedThe footer’s ClinicalTrials.gov revision number changed from v3.7.0 to v3.7.1 while the page continued to display a 403 error.SummaryDifference0.2%

- Check11 days agoNo Change Detected
- Check18 days agoChange DetectedRemoved the 403 Forbidden error page content and its HTML markup that displayed when access to the study page was blocked.SummaryDifference0.5%

- Check25 days agoChange DetectedThe page now returns a 403 Forbidden error, replacing the study details with an error page. This indicates access restrictions that prevent viewing the trial information on this URL.SummaryDifference20%

- Check46 days agoChange DetectedThe page revision was updated from v3.6.5 to v3.6.6, indicating a small page update or quality control pass.SummaryDifference0.1%

- Check67 days agoChange DetectedThe page revision was updated from v3.6.4 to v3.6.5, indicating a new publication revision. This reflects a metadata update rather than a substantive alteration to study content.SummaryDifference0.1%

- Check82 days agoChange DetectedRevision updated from v3.6.3 to v3.6.4 on the page. This indicates a newer page revision.SummaryDifference0.1%

Stay in the know with updates to iTRAP: ADI-PEG 20 Combo in Arginine-Req Tumours Clinical Trial
Enter your email address, and we'll notify you when there's something new on the iTRAP: ADI-PEG 20 Combo in Arginine-Req Tumours Clinical Trial page.